These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20695297)

  • 41. Valproate and cytochrome c oxidase deficiency.
    Ponchaut S; Van Hoof F; Veitch K
    Eur J Pediatr; 1995 Jan; 154(1):79. PubMed ID: 7895762
    [No Abstract]   [Full Text] [Related]  

  • 42. Valproate toxicity.
    Parra J; Iriarte J; Pierre-Louis SJ
    Neurology; 1996 Dec; 47(6):1608. PubMed ID: 8960763
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pediatric stress-induced epileptic ataxia syndrome caused by ADPRHL2 gene variation].
    Xu MT; Fang F; Holger P; Liu ZM; Ren XT; Li JW; Feng WX; Zeng JS; He LJ
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):503-505. PubMed ID: 32521964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurogenetics: The expanding horizons of diagnosis and disease pathogenesis.
    Gomez CM; Kawakami H
    Neurology; 2015 Mar; 84(11):1070-1. PubMed ID: 25681450
    [No Abstract]   [Full Text] [Related]  

  • 45.
    Ng PS; Pinto MV; Neff JL; Hasadsri L; Highsmith EW; Fidler ME; Gavrilova RH; Klein CJ
    Neurol Genet; 2019 Apr; 5(2):e314. PubMed ID: 31041396
    [No Abstract]   [Full Text] [Related]  

  • 46. Gastrointestinal manifestations of mitochondrial disorders: a systematic review.
    Finsterer J; Frank M
    Therap Adv Gastroenterol; 2017 Jan; 10(1):142-154. PubMed ID: 28286566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do carriers of POLG mutation W748S have disease manifestations?
    Rantamäki M; Luoma P; Virta JJ; Rinne JO; Paetau A; Suomalainen A; Udd B
    Clin Genet; 2007 Dec; 72(6):532-7. PubMed ID: 17894835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T-->C mutation.
    Rantamäki MT; Soini HK; Finnilä SM; Majamaa K; Udd B
    Ann Neurol; 2005 Aug; 58(2):337-40. PubMed ID: 16049925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
    Hynynen J; Komulainen T; Tukiainen E; Nordin A; Arola J; Kälviäinen R; Jutila L; Röyttä M; Hinttala R; Majamaa K; Mäkisalo H; Uusimaa J
    Liver Transpl; 2014 Nov; 20(11):1402-12. PubMed ID: 25065347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mitochondrial recessive ataxia syndrome (MIRAS) and valproate toxicity].
    Hakonen AH; Isohanni P; Rantamäki M; Kälviäinen R; Nordin A; Uusimaa J; Paetau A; Udd B; Pihko H; Wartiovaara A
    Duodecim; 2010; 126(13):1552-9. PubMed ID: 20695297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpers syndrome: progressive neuronal degeneration of children with liver disease.
    Gordon N
    Dev Med Child Neurol; 2006 Dec; 48(12):1001-3. PubMed ID: 17109792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial ataxias.
    Finsterer J
    Can J Neurol Sci; 2009 Sep; 36(5):543-53. PubMed ID: 19831121
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.